Results 101 to 110 of about 662,880 (268)

Real‐World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry

American Journal of Hematology, Volume 101, Issue 5, Page 939-948, May 2026.
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth, Christopher J. Patriquin, Jeff Szer, Louis Terriou, Ami S. Patel, Jesse Metzger, Philippe Gustovic, Jun‐ichi Nishimura, Robert A. Brodsky   +8 more
wiley   +1 more source

Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease

ARYA Atherosclerosis, 2016
BACKGROUND: High-sensitivity C-reactive protein (hs-CRP) inflammatory biomarker is one of the best informative markers of prognosis of coronary artery disease (CAD) that has been studied.
Seyed Masoud Seyedian, Farzaneh Ahmadi, Razieh Dabagh, Hannaneh Davoodzadeh   +3 more
doaj  

Angina Pectoris - A general practice review: Part I

South African Family Practice, 1989
No abstract available.
E.L. Murray
doaj   +1 more source

Causal attributions, lifestyle change and coronary heart disease: illness beliefs of patients of South Asian and European origin living in the UK [PDF]

, 2008
OBJECTIVE We examined and compared the illness beliefs of South Asian and European patients with coronary heart disease (CHD) about causal attributions and lifestyle change.
Ahmad, Aliya Darr, Astin, Atkin, Atkin, Carroll, Chaturvedi, Cherrington, Coutu, De Backer, Dominelli, Farooqi, Felicity Astin, French, Fukuoka, Higham, Horne, Jayaratnam, Karl Atkin, Karlsen, Kuppuswamy, Leventhal, Murphy, Nazroo, Papadopoulos, Petrie, Pyorala, Richie, Silverman, Skelton, Tod, Webster, Wild, Zerwic   +33 more
core   +1 more source

Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1265-1274, May 2026.
With the increasing volume of clinical evidence derived from large‐scale Asian real‐world data (RWD) and the growing interest in its use in regulatory decision‐making, it is important to conduct benchmarking exercises that evaluate whether studies using Asian RWD can generate similar conclusions as randomized controlled trials (RCTs).
Hwa Yeon Ko, Philip C. M. Au, Michael Chun‐Yuan Cheng, Ching‐Lung Cheung, Ahhyung Choi, Miyuki Hsing‐Chun Hsieh, Han Eol Jeong, Edward Chia‐Cheng Lai, Brian Meng‐Hsun Li, Kenneth K. C. Man, Jeremy A. Rassen, Daniel Hsiang‐Te Tsai, Shirley V. Wang, Ian C. K. Wong, Ju‐Young Shin, Sohee Park   +15 more
wiley   +1 more source

THE INFLUENCE OF CELL AND PLASMA HEMOSTASIS AND BIOMARKER LEVELS ON CLINICAL OUTCOMES IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS

Евразийский Кардиологический Журнал, 2016
SUMMARY Objective: to assess the impact of cell plasma hemostasis disorders and the level of biomarkers on clinical outcomes and to develop laboratory diagnostic criteria forecast recurrent coronary events in patients with unstable angina.
L. G. Gelis, E. A. Medvedeva, I. I. Russkich, I. V. Lazareva, T. . Rusak, A. V. Tamashevsky   +5 more
doaj   +1 more source

Cardiovascular Benefits of Salvia miltiorrhiza (Danshen) Supplementation: Bioactive Constituents, Mechanisms, Clinical Evidence and Implications for Nutritional Care

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Salvia miltiorrhiza (Danshen) contains bioactive tanshinones, including tanshinone IIA, cryptotanshinone, and tanshinone I, that exert cardioprotective effects through coordinated modulation of vascular endothelial growth factor receptor (VEGFR), transforming growth factor beta 1 (TGF‐β1), transforming growth factor beta receptor (TGF‐βR), toll‐like ...
Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi, William N. Setzer, Javad Sharifi‐Rad, Daniela Calina   +6 more
wiley   +1 more source

ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME

Рациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate the pre-hospital treatment of patients with acute coronary syndromes (acute myocardial infarction and unstable angina) in 2001 and 2006.Material and methods. Retrospective pre-hospital treatment survey was performed in 1114 patients with
O. V. Reshetko, R. M. Magdeev, N. V. Furman   +2 more
doaj   +1 more source

Relationship of some risk factors and symptoms in patients with acute coronary syndrome [PDF]

, 2012
Acute coronary syndrome (ACS) is one of the major causes of death in the worldwide. Clinical manifestations are different. So it's necessary to have knowledge about the types of symptoms experienced by patients with ACS. This study was performed to assay
Afshar, M.H., Bahrami, N., Beheshti, Z., Ghana, S., Haghdoost, A.A., Nazari, R., Nia, H.S., Soleimani, M.A.   +7 more
core  

Diagnostic Accuracy of Cardiovascular Disease Prediction Models: A Systematic Review and Meta‐Analysis of Validation Studies

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aim Cardiovascular diseases (CVD) are widely accepted to be the most serious health care problem in the world. We performed a diagnostic test accuracy systematic review and meta‐analysis to establish the real‐world performance of established CVD risk prediction tools, providing high‐certainty evidence to optimize primary ...
Mohammad Aziz Rasouli, Farid Najafi, Alireza Ansari‐Moghaddam, Bijan Nouri, Farhad Moradpour, Ghobad Moradi, Yousef Moradi   +6 more
wiley   +1 more source